{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T05:05:58Z","timestamp":1649135158184},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gaceta Sanitaria"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.gaceta.2009.08.008","type":"journal-article","created":{"date-parts":[[2009,12,11]],"date-time":"2009-12-11T15:12:39Z","timestamp":1260544359000},"page":"171.e1-171.e6","source":"Crossref","is-referenced-by-count":1,"title":["En el camino para acortar los tratamientos de la tuberculosis: los ensayos cl\u00ednicos de la Unitat d'Investigaci\u00f3 en la Tuberculosi de Barcelona impulsados por los Centres for Disease Control and Prevention"],"prefix":"10.1016","volume":"24","author":[{"given":"Antonio","family":"Moreno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanne","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 M.","family":"Mir\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan A.","family":"Cayl\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gaceta.2009.08.008_bib1","unstructured":"WHO report 2008. Global tuberculosis control - surveillance, planning, financing. Disponible en: http:\/\/www.who.int\/tb\/publications\/global_report\/2008\/key_points\/en\/index.html"},{"key":"10.1016\/j.gaceta.2009.08.008_bib2","first-page":"943","article-title":"Conducting clinical trials on tuberculosis in resource-poor countries: imposed science or equally-shared efforts?","volume":"9","author":"Lienhardt","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"issue":"suppl 1","key":"10.1016\/j.gaceta.2009.08.008_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1472-9792(08)70035-0","article-title":"Experimental tuberculosis: the role of comparative pathology in the discovery of improved tuberculosis treatment strategies","volume":"88","author":"Basaraba","year":"2008","journal-title":"Tuberculosis"},{"issue":"suppl 1","key":"10.1016\/j.gaceta.2009.08.008_bib4","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/S1472-9792(08)70039-8","article-title":"Design issues in pivotal drug trials for drug sensitive tuberculosis (tuberculosis)","volume":"88","author":"Nunn","year":"2008","journal-title":"Tuberculosis"},{"key":"10.1016\/j.gaceta.2009.08.008_bib5","doi-asserted-by":"crossref","first-page":"e302","DOI":"10.1371\/journal.pmed.0040302","article-title":"Building clinical trials capacity for tuberculosis drugs in high-burden countries","volume":"4","author":"Schluger","year":"2007","journal-title":"PloS Med"},{"key":"10.1016\/j.gaceta.2009.08.008_bib6","doi-asserted-by":"crossref","first-page":"e293","DOI":"10.1371\/journal.pmed.0040293","article-title":"New approaches to filling the gap in tuberculosis drug discovery","volume":"4","author":"Casenghi","year":"2007","journal-title":"PloS Med"},{"key":"10.1016\/j.gaceta.2009.08.008_bib7","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.7164\/antibiotics.37.1066","article-title":"Pharmacokinetics of rifapentine, a new long-acting rifamycin, in the rat, the mouse, and the rabbit","volume":"37","author":"Assandri","year":"1984","journal-title":"J Antibiot"},{"key":"10.1016\/j.gaceta.2009.08.008_bib8","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.1164\/ajrccm.161.supplement_3.ats600","article-title":"Targeted tuberculin testing and treatment of latent tuberculosis infection","volume":"161","author":"American Thoracic Society, Centers for Disease Control and Prevention","year":"2000","journal-title":"Am J Resp Crit Care Med"},{"key":"10.1016\/j.gaceta.2009.08.008_bib9","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1128\/AAC.46.6.1875-1879.2002","article-title":"Bactericidal activity of increasing daily and weekly doses of moxifloxacin in murine tuberculosis","volume":"46","author":"Yoshimatsu","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.gaceta.2009.08.008_bib10","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1164\/rccm.167.4.603","article-title":"Treatment of tuberculosis","volume":"167","author":"American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.gaceta.2009.08.008_bib11","first-page":"24","article-title":"Consenso Nacional para el Control de la Tuberculosis en Espa\u00f1a","volume":"98","author":"Grupo de Trabajo sobre Tuberculosis","year":"1992","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.gaceta.2009.08.008_bib12","doi-asserted-by":"crossref","unstructured":"Dorman S, et al. Moxifloxacin vs. isoniazid in the first 2 months of treatment for pulmonary tuberculosis. 47th Interscience Conference on Antimicrobial Agents and Chemotherapy; Chicago, 2007; abst. L-736-B.","DOI":"10.1016\/S0084-3873(08)70064-6"},{"key":"10.1016\/j.gaceta.2009.08.008_bib13","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1164\/rccm.200602-280OC","article-title":"Potent twice-weekly rifapentine-containing regimens in murine tuberculosis","volume":"174","author":"Rosenthal","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.gaceta.2009.08.008_bib14","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1164\/rccm.200201-047OC","article-title":"A prospective, randomized, double-blind study of the tolerability of rifapentine 600, 9000 and 1,200mg plus isoniazid in the continuation phase of tuberculosis treatment","volume":"165","author":"Bock","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.gaceta.2009.08.008_bib15","unstructured":"Registro Nacional de Casos de Sida. Informe semestral. No 1, a\u00f1o 2008. Disponible en: http:\/\/www.isciii.es\/htdocs\/centros\/epidemiologia\/pdf\/SPNS_Informe_semestral.pdf"},{"key":"10.1016\/j.gaceta.2009.08.008_bib16","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1157\/13106563","article-title":"Situaci\u00f3n actual de las resistencias de Mycobacterium tuberculosis en la poblaci\u00f3n inmigrante de la Comunidad de Madrid","volume":"43","author":"Sanz Barbero","year":"2007","journal-title":"Archiv Bronconeumol"},{"key":"10.1016\/j.gaceta.2009.08.008_bib17","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1157\/13111347","article-title":"Microepidemias de tuberculosis en cinco brotes escolares: importancia de la tipificaci\u00f3n gen\u00e9tica de la cepas en su evaluaci\u00f3n e interpretaci\u00f3n","volume":"43","author":"Marcos Rodr\u00edguez","year":"2007","journal-title":"Archiv Bronconeumol"},{"key":"10.1016\/j.gaceta.2009.08.008_bib18","first-page":"1102","article-title":"A controlled trial by the British Thoracic and Tuberculosis Association","volume":"308","author":"Short-Course chemotherapy in pulmonary tuberculosis","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.gaceta.2009.08.008_bib19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0041-3879(75)90034-3","article-title":"Hong Kong Tuberculosis Treatment Services\/British Medical Research Council Study of short-course regimen of streptomycin, isoniazid and pyrazinamide: latest results","volume":"56","author":"Girling","year":"1975","journal-title":"Tubercle"},{"key":"10.1016\/j.gaceta.2009.08.008_bib20","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0041-3879(75)90033-1","article-title":"Latest results of east African\/British Medical Research Council short-course chemotherapy studies","volume":"56","author":"Heffergram","year":"1975","journal-title":"Tubercle"},{"key":"10.1016\/j.gaceta.2009.08.008_bib21","first-page":"466","article-title":"A comparative study of initial daily triple or fourth drugs","volume":"121","author":"Cooperative Tuberculosis Chemotherapy Study in Poland (National Research Institut Warsaw and Center for Disease Control, Atlanta)","year":"1980","journal-title":"Am Rev Resp Dis"},{"issue":"suppl","key":"10.1016\/j.gaceta.2009.08.008_bib22","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1378\/chest.76.6_Supplement.785","article-title":"The chemotherapy of pulmonary tuberculosis: a review","volume":"76","author":"Fox","year":"1979","journal-title":"Chest"},{"key":"10.1016\/j.gaceta.2009.08.008_bib23","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1086\/518663","article-title":"New tuberculosis therapeutics: a growing pipeline","volume":"196","author":"Spigelman","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.gaceta.2009.08.008_bib24","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1128\/AAC.01326-06","article-title":"Drug therapy of experimental tuberculosis (tuberculosis): improved outcome by combining SQ109, a new diamine antibiotic, with existing tuberculosis drugs","volume":"51","author":"Nikonenko","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.gaceta.2009.08.008_bib25","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1128\/AAC.00074-08","article-title":"Powerful bactericidal and sterilizing activity of a regimen containing PA-824, moxifloxacin, and pyrazinamide in a murine model of tuberculosis","volume":"52","author":"Nuemberger","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.gaceta.2009.08.008_bib26","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1128\/JCM.00177-08","article-title":"Prevention of drug carry-over effects in studies assessing the antimycobacterial efficacy of TMC207","volume":"46","author":"Lounis","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.gaceta.2009.08.008_bib27","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/jac\/dkm291","article-title":"Bactericidal activity of OPC-67683 against drug-tolerant Mycobacterium tuberculosis","volume":"60","author":"Saliu","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.gaceta.2009.08.008_bib28","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.tube.2006.01.024","article-title":"RUTI: a new chance to shorter the treatment of latent tuberculosis infection","volume":"86","author":"Cardona","year":"2006","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.gaceta.2009.08.008_bib29","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/jac\/dkl298","article-title":"Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistan tuberculosis","volume":"58","author":"Park","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.gaceta.2009.08.008_bib30","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0300-2896(08)75773-9","article-title":"Tuberculosis y solidaridad","volume":"44","author":"Cayl\u00e0","year":"2008","journal-title":"Archiv Bronconeumol"}],"container-title":["Gaceta Sanitaria"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213911109003719?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213911109003719?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T12:42:03Z","timestamp":1558701723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213911109003719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0213911109003719"],"URL":"https:\/\/doi.org\/10.1016\/j.gaceta.2009.08.008","relation":{},"ISSN":["0213-9111"],"issn-type":[{"value":"0213-9111","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}